CDK5 and Parkinson disease: Interestingly, in PD, Cdk5 was shown to activate NLRP3, suggesting that inflammasome inhibitors may lower the detrimental effects of this kinase on neurons, preventing senescence and cell cycle engagement (Zhang et al., 2016).